Maravai LifeSciences Holdings, Inc. Retained Earnings
Maravai LifeSciences Holdings, Inc. (MRVI) had Retained Earnings of -$6.03 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-07
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$6.03M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) $6.38M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) $10.12M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) $45.80M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$6.03M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $6.38M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $10.12M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $45.80M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $71.36M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $110.95M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $140.89M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $166.80M 10-K · filed 2025-03-18 | $167.04M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $263.87M 10-K · filed 2025-03-18 | $266.07M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $273.66M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $285.74M 10-K · filed 2025-03-18 | |
| 2023-09-30 | $391.70M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $398.16M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $404.70M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $404.77M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $367.13M 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $322.66M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $251.42M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $184.56M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $128.73M 10-Q · filed 2022-11-04 | $127.45M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $74.77M 10-Q · filed 2022-08-05 | $73.18M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $25.63M 10-Q · filed 2022-05-06 | $24.10M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $854.00K 10-K · filed 2022-03-01 |